l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
- 2018-01
- RCT · n = 54
- Nutrition research (New York, N.Y.) 49
- Shiva Houjeghani
- Sorayya Kheirouri
- Esmaeil Faraji
- Mohammad Asghari Jafarabadi
- PubMed: 29420997
- DOI: 10.1016/j.nutres.2017.11.003
- High evidence
- Clinical
A significant reduction in ... glycated hemoglobin (.6%) ... was detected in the l-carnosine group compared with the placebo group (P<.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 2 capsules of l-carnosine 500 mg each (1000 mg/day)